Latest Cost Management News

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Mayfield Childcare Limited reported a 5% revenue increase and a 14% rise in underlying EBITDA for Q3 FY25, alongside a $2.4 million debt reduction and an extended borrowing facility. The company also ended a planned divestment and announced a new community partnership.

WOTSO’s flexspace segment sustained growth in Q4 FY25 with a 4% year-on-year revenue increase, opening four new locations and expanding its footprint by 9%. Occupancy dipped slightly but remains robust at 75%.

Otto Energy reported an 11% rise in oil production and a solid US$2 million net operating cash inflow in Q3 2025, alongside key executive and board changes.

GWA reported modest revenue and earnings growth in FY25, driven by strong performance in Australia and the UK despite a tough New Zealand market. The company also initiated a $30 million on-market share buyback and increased its fully franked dividend.

Enlitic, Inc. reported a strong quarter with record cash receipts and contract wins, yet withdrew its revenue guidance due to delayed project completions. The company remains confident in reaching operational cash flow break-even by the end of Q4 FY25.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Australian Bond Exchange Holdings (ASX – ABE) unveiled new AUD-denominated market-linked securities and progressed its AI-driven credit analysis tool, while reporting a $0.7 million quarterly cash outflow and plans for capital raising.

BSA Limited’s Q1 FY2026 results reveal a sharp revenue drop following the expiration of its key nbn contract, alongside a major workforce reduction and strategic pivot.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launching its Mining-IQ AI platform and securing a landmark $550k contract with Rio Tinto.

Hydralyte USA reported a 6% year-on-year sales increase in Q3 FY25 alongside a significant 42% reduction in operating cash burn, driven by a streamlined US-focused model and new product launches in brain and gut health.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.